fig10
Figure 10. Schematic showing the three general stages (pre-clinical testing, clinical trials, and the review/approval process) of the FDA’s drug approval process. Drug approval percentages reflect FDA data from 2006-2015 analyzed by the US Government Accountability Office (GAO) through a collaborative study with the Biotechnology Innovation Organization, Biomedtracker, and Amplion (GAO 117-564)[385,386].
